参考文献/References:
[1] Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.DOI:10.3322/caac.21338.
[2] Valderrabano P,McIver B.Evaluation and management of indeterminate thyroid nodules: the revolution of risk stratification beyond cytological diagnosis[J]. Cancer Control,2017,24(5):1073274817729231.DOI:10.1177/1073274817729231.
[3] Decaussin-Petrucci M,Descotes F,Depaepe L,et al. Molecular testing of BRAF, RAS and TERT on thyroid FNAs with indeterminate cytology improves diagnostic accuracy[J].Cytopathology,2017,28(6):482-487.DOI:10.1111/cyt.12493.
[4] Insilla AC,Proietti A,Borrelli N,et al.TERT promoter mutations and their correlation with BRAF and RAS mutations in a consecutive cohort of 145 thyroid cancer cases[J].Oncol Lett,2018,15(3):2763-2770.DOI:10.3892/ol.2017.7675.
[5] Dolatabadian A,Patel DA,Edwards D,et al.Copy number variation and disease resistance in plants[J].Theor Appl Genet,2017,130(12):2479-2490.DOI:10.1007/s00122-017-2993-2.
[6] Richardson SR,Doucet AJ,Kopera HC,et al.The influence of LINE-1 and SINE retrotransposons on mammalian genomes[J].Microbiol Spectr,2015,3(2):MDNA3-0061-2014.DOI:10.1128/microbiolspec.MDNA3-0061-2014.
[7] Park TJ,Hwang MY,Moon S,et al.Identification of a copy number variation on chromosome 20q13.12 associated with osteoporotic fractures in the Korean population[J].Genomics Inform,2016,14(4):216-221.DOI:10.5808/GI.2016.14.4.216.
[8] Shaikh TH.Copy number variation disorders[J].Curr Genet Med Rep,2017,5(4):183-190.DOI:10.1007/s40142-017-0129-2.
[9] VanderWeele DJ,Finney R,Katayama K,et al.Genomic heterogeneity within individual prostate cancer foci impacts predictive biomarkers of targeted therapy[J].Eur Urol Focus,2018,pii:S2405-S4569(18)30007-5.DOI:10.1016/j.euf.2018.01.006.
[10] Schumacher SE,Shim BY,Corso G,et al.Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients[J].PLoS One,2017,12(4):e0176045. DOI:10.1371/journal.pone.0176045.
[11] Woo HG,Choi JH,Yoon S,et al.Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer[J].Nat Commun,2017,8(1):839.DOI:10.1038/s41467-017-00991-w.
[12] Kaveh F,Baumbusch LO,Nebdal D,et al.A systematic comparison of copy number alterations in four types of female cancer[J].BMC Cancer,2016,16(1):913.DOI:10.1186/s12885-016-2899-4.
[13] Liu S,Song L,Cram DS,et al.Traditional karyotyping vs copy number variation sequencing for detection of chromosomalabnormalities associated with spontaneous miscarriage[J].Ultrasound Obstet Gynecol,2015,46(4):472-477.DOI:10.1002/uog.14849.
[14] Hollox EJ.Analysis of copy number variation using the paralogue ratio test(PRT)[J].Methods Mol Biol,2017,1492:127-146.DOI:10.1007/978-1-4939-6442-0_8.
[15] Reiner J,Karger L,Cohen N,et al.Chromosomal microarray detection of constitutional copy number variation using saliva DNA[J].J Mol Diagn,2017,19(3):397-403.DOI:10.1016/j.jmoldx.2016.11.006.
[16] Ko JM.Chromosomal microarray: application for congenital heart diseases[J].Korean Circ J,2018,48(3):233-235.DOI:10.4070/kcj.2018.0032.
[17] López S,García I,Smith I,et al.Discovery of copy number variants by multiplex amplifiable probe hybridization(MAPH)in candidate pigmentation genes[J].Ann Hum Biol,2015,42(5):485-493.DOI:10.3109/03014460.2014.965202.
[18] Marcinkowska-Swojak M,Uszczynska B,Figlerowicz M,et al.An MLPA-based strategy for discrete CNV genotyping: CNV-miRNAs as an example[J].Hum Mutat,2013,34(5):763-773.DOI:10.1002/humu.22288.
[19] Fukami M,Miyado M.Next generation sequencing and array-based comparative genomic hybridization for molecular diagnosis of pediatric endocrine disorders[J].Ann Pediatr Endocrinol Metab,2017,22(2):90-94.DOI:10.6065/apem.2017.22.2.90.
[20] Pirooznia M,Goes FS,Zandi PP.Whole-genome CNV analysis:advances in computational approaches[J].Front Genet,2015,6:138.DOI:10.3389/fgene.2015.00138.
[21] Da Silva L,James D,Simpson PT,et al.Tumor heterogeneity in a follicular carcinoma of thyroid: a study by comparative genomic hybridization[J].Endocr Pathol,2011,22(2):103-107.DOI:10.1007/s12022-011-9154-y.
[22] Liu Y,Cope L,Sun W,et al.DNA copy number variations characterize benign and malignant thyroid tumors[J].J Clin Endocrinol Metab,2013,98(3):E558-E566.DOI:10.1210/jc.2012-3113.
[23] Hess J,Thomas G,Braselmann H,et al.Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiation[J].Proc Natl Acad Sci U S A,2011,108(23):9595-9600.DOI:10.1073/pnas.1017137108.
[24] Ye L,Zhou X,Huang F,et al.The genetic landscape of benign thyroid nodules revealed by whole exome and transcriptome sequencing[J].Nat Commun,2017,8:15533. DOI:10.1038/ncomms15533.
[25] Cancer Genome Atlas Research Network.Integrated genomic characterization of papillary thyroid carcinoma[J].Cell,2014,159(3):676-690.DOI:10.1016/j.cell.2014.09.050.
[26] Yoo SK,Lee S,Kim SJ,et al.Comprehensive analysis of the transcriptional and mutational landscape of follicular and papillary thyroid cancers[J].PLoS Genet,2016,12(8):e1006239.DOI:10.1371/journal.pgen.1006239.
[27] Passon N,Bregant E,Sponziello M,et al.Somatic amplifications and deletions in genome of papillary thyroid carcinomas[J].Endocrine,2015,50(2):453-464.DOI:10.1007/s12020-015-0592-z.
[28] Ciampi R,Romei C,Cosci B,et al.Chromosome 10 and RET gene copy number alterations in hereditary and sporadic medullary thyroid carcinoma[J].Mol Cell Endocrinol,2012,348(1):176-182.DOI:10.1016/j.mce.2011.08.004.
[29] Liang J,Cai W,Feng D,et al.Genetic landscape of papillary thyroid carcinoma in the Chinese population[J].J Pathol,2018,244(2):215-226.DOI:10.1002/path.5005.
[30] Matsuse M,Sasaki K,Nishihara E,et al.Copy number alteration and uniparental disomy analysis categorizes Japanese papillary thyroid carcinomas into distinct groups[J].PLoS One,2012,7(4):e36063.DOI:10.1371/journal.pone.0036063.
[31] Zitzelsberger H,Unger K.DNA copy number alterations in radiation-induced thyroid cancer[J].Clin Oncol(R Coll Radiol),2011,23(4):289-296.DOI:10.1016/j.clon.2011.01.154.
[32] Kurelac I,de Biase D,Calabrese C,et al.High-resolution genomic profiling of thyroid lesions uncovers preferential copy numbergains affecting mitochondrial biogenesis loci in the oncocytic variants[J].Am J Cancer Res,2015,5(6):1954-1971.
[33] Duquette M,Sadow PM,Husain A,et al.Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model[J].Oncotarget,2015,6(40):42445-42467.DOI:10.18632/oncotarget.6442.
[34] Wang N,Kjellin H,Sofiadis A,et al.Genetic and epigenetic background and protein expression profiles in relation to telomerase activation in medullary thyroid carcinoma[J].Oncotarget,2016,7(16):21332-21346.DOI:10.18632/oncotarget.7237.
[35] Grubbs EG,Williams MD,Scheet P,et al.Role of CDKN2C copy number in sporadic medullary thyroid carcinoma[J].Thyroid,2016,26(11):1553-1562.DOI:10.1089/thy.2016.0224.
相似文献/References:
[1]张蓉,俞立波,李连喜.组蛋白修饰与甲状腺癌[J].国际内分泌代谢杂志,2014,(05):348.[doi:10.3760/cma.j.issn.1673-4157.2014.05.017]
Zhang Rong,Yu Libo,Li Lianxi..Histone modification and thyroid tumor[J].International Journal of Endocrinology and Metabolism,2014,(01):348.[doi:10.3760/cma.j.issn.1673-4157.2014.05.017]
[2]李兴佳,徐书杭,刘超.雌激素及其受体与甲状腺癌的关系[J].国际内分泌代谢杂志,2016,36(04):273.[doi:10.3760/cma.j.issn.1673-4157.2016.04.15]
Li Xingjia,Xu Shuhang,Liu Chao.Relationship between estrogen, its receptors and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2016,36(01):273.[doi:10.3760/cma.j.issn.1673-4157.2016.04.15]
[3]郑仁东,刘超.白细胞介素-6与甲状腺疾病[J].国际内分泌代谢杂志,2016,36(05):352.[doi:10.3760/cma.j.issn.1673-4157.2016.05.18]
Zheng Rendong,Liu Chao.Interleukin-6 and thyroid disease[J].International Journal of Endocrinology and Metabolism,2016,36(01):352.[doi:10.3760/cma.j.issn.1673-4157.2016.05.18]
[4]郑仁东,刘超.STAT3与甲状腺肿瘤[J].国际内分泌代谢杂志,2017,37(05):345.
Zheng Rendong,Liu Chao..STAT3 and thyroid tumor[J].International Journal of Endocrinology and Metabolism,2017,37(01):345.
[5]孟祥慧 徐书杭 陈国芳 刘超.二甲双胍在甲状腺癌防治中的作用[J].国际内分泌代谢杂志,2018,38(04):237.[doi:10.3760/cma.j.issn.1673-4157.2018.04.005]
Meng Xianghui*,Xu Shuhang,Chen Guofang,et al.Role of metformin in prevention and treatment of thyroid cancer[J].International Journal of Endocrinology and Metabolism,2018,38(01):237.[doi:10.3760/cma.j.issn.1673-4157.2018.04.005]
[6]张会峰 胡天赤 陈学勤 叶向荣 刘超.丙型肝炎病毒感染与自身免疫性甲状腺疾病
及甲状腺癌风险[J].国际内分泌代谢杂志,2019,39(02):128.[doi:10.3760/cma.j.issn.1673-4157.2019.02.014]
Zhang Huifeng,Hu Tianchi,Chen Xueqin,et al.Relationship between hepatitis C virus infection and the risk of autoimmune thyroid diseases and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2019,39(01):128.[doi:10.3760/cma.j.issn.1673-4157.2019.02.014]
[7]张玉洁 孟召伟 章明放 宋丽丽 李宁.甲状腺疾病的代谢组学研究现状[J].国际内分泌代谢杂志,2019,39(03):173.[doi:10.3760/cma.j.issn.1673-4157.2019.03.007]
Zhang Yujie,Meng Zhaowei,Zhang Mingfang,et al.Research status of metabolomics in thyroid diseases[J].International Journal of Endocrinology and Metabolism,2019,39(01):173.[doi:10.3760/cma.j.issn.1673-4157.2019.03.007]
[8]田勍,洪天配.甲状腺结节诊治过程中的难点与应对[J].国际内分泌代谢杂志,2021,41(06):557.[doi:10.3760/cma.j.cn121383-20210727-07074]
Tian Qing,Hong Tianpei..Difficulties and countermeasures in the diagnosis and treatment of thyroid nodules[J].International Journal of Endocrinology and Metabolism,2021,41(01):557.[doi:10.3760/cma.j.cn121383-20210727-07074]
[9]张雅,相萍萍,徐书杭,等.经皮无水乙醇注射治疗甲状腺结节:老方法的新认识[J].国际内分泌代谢杂志,2022,42(06):469.[doi:10.3760/cma.j.cn121383-20210926-09075]
Zhang Ya,Xiang Pingping,Xu Shuhang,et al.Percutaneous ethanol ablation for thyroid nodules: new perspectives on an old paradigm[J].International Journal of Endocrinology and Metabolism,2022,42(01):469.[doi:10.3760/cma.j.cn121383-20210926-09075]